Grantham, Mayo, Van Otterloo & Co (GMO)’s ACM Research ACMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-3,713
Closed -$471K – 685
2026
Q2
$471K Sell
3,713
-6,468
-64% -$457K ﹤0.01% 571
2026
Q1
$401K Sell
10,181
-10,106
-50% -$536K ﹤0.01% 566
2025
Q4
$800K Buy
20,287
+1,686
+9% +$62.8K ﹤0.01% 538
2025
Q3
$728K Buy
+18,601
New +$552K ﹤0.01% 503

Other funds holding ACMR

Grantham, Mayo, Van Otterloo & Co (GMO)'s ACMR Position: Q3 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of ACM Research (ACMR) in Q3 2026, closing a stake of 3,713 shares — an estimated $471K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ACMR in Q3 2025 and held it in 4 quarters. The position peaked at $800K in Q4 2025. 382 funds tracked by Wall St. Rank hold ACMR as of Q3 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining ACM Research position as of Q3 2026 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 3,713 ACM Research shares in Q3 2026, an estimated $471K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ACM Research in Q3 2025 and held it in 4 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ACM Research position peaked at $800K in Q4 2025.
  • 382 funds tracked by Wall St. Rank held ACM Research as of Q3 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2026, filed 13 Nov 2026.